Tuesday
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
Location: Grand Ballroom East, 3rd Floor
Moderators:Caron B. Rockman, MD / Michel Makaroun, MD / Grace J. Wang, MD, MSCE  
SESSION 5 SCHEDULE
1:00 PM - 1:05 PM Unexpected Small Bowel Necrosis When Performing EVAR In Patients With Visceral Artery (SMA) Occlusive Disease: How To Predict It And How To Avoid It
  Presenter(s):Karan Garg, MD / Neal S. Cayne, MD / Carlos H. Timaran, MD / Frank J. Veith, MD  
Location: Grand Ballroom East, 3rd Floor
1:06 PM - 1:11 PM New Medical Therapies For AAA Disease And An Update On The Metformin Trials For Slowing Aneurysm Growth
  Presenter(s):Ronald L. Dalman, MD  
Location: Grand Ballroom East, 3rd Floor
1:12 PM - 1:17 PM DEBATE: The Safe-AAA Study Emphasizes The Importance Of Ongoing Surveillance And Continuing EVAR Device Risk: Some EVAR Endografts Have Been Found To Have More Late Risks Than Others
  Presenter(s):Philip P. Goodney, MD, MS / Eric A. Secemsky, MD, MSc  
Location: Grand Ballroom East, 3rd Floor
1:18 PM - 1:23 PM DEBATE: Patient Survival After EVAR Was NOT Improved By Compliance With Surveillance Protocols: The EVAR Surveillance Paradox: From A Systematic Meta-Analysis: What Is The Explanation
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
Location: Grand Ballroom East, 3rd Floor
1:24 PM - 1:29 PM Computer Analysis Of CT Factors Determining AAA Wall Weakness/Strength Of Areas In AAAs Predicts Rupture Risk Independent Of Size And Post EVAR Neck Behavior: The ViTAA System
  Presenter(s):Randy D. Moore, MD  
Location: Grand Ballroom East, 3rd Floor
1:30 PM - 1:35 PM Value Of Properly Performed Ch/EVAR For Juxtarenal AAAs: Results From A Single Center With The Longest Available Follow-Up Confirm Long-Term Safety And Effectiveness: Technique Is Vital
  Presenter(s):Joost van Herwaarden, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
1:36 PM - 1:41 PM Panel Discussion
1:42 PM - 1:47 PM Update On An Interesting New Endovascular Technology (Nectero – Intra-Sac Drug After AAA Balloon Isolation) To Slow AAA Growth: Updated Clinical Results Of The First-In-Human Trial
  Presenter(s):Andrew Holden, MBChB / Daniel G. Clair, MD / Venkatesh G. Ramaiah, MD  
Location: Grand Ballroom East, 3rd Floor
1:48 PM - 1:53 PM Short And Long-Term Results For Endovascular Therapy For Infected Aortic Aneurysms At Various Levels: An 18-Year, >163-Case Experience: EVAR Can Work
  Presenter(s):Boonprasit Kritpracha, MD  
Location: Grand Ballroom East, 3rd Floor
1:54 PM - 1:59 PM Size Thresholds For Repair Of AAAs Are Wrong On The Low Side: Data From Medicare And The VQI Indicate That Rupture Risk Only Increases With AAAs Over 6-6.9 cm
  Presenter(s):David H. Stone, MD / Sal Scali, MD / Bjoern D. Suckow, MD  
Location: Grand Ballroom East, 3rd Floor
2:00 PM - 2:05 PM Update On Long-Term Results From The Dream RCT Comparing EVAR With Open Repair For AAAs Suitable For Both: Adverse Neck Anatomy (Short, Wide, Angulated) Was Associated With Increased Reintervention And Mortality Rates Equally After Open And Endo Repairs: Neck Dilatation Only Occurs After Open Repair And In EVARs With Self-Expanding Endografts: How Should This Influence Today’s Treatment
  Presenter(s):Jan D. Blankensteijn, MD  
Location: Grand Ballroom East, 3rd Floor
2:06 PM - 2:11 PM DEBATE: Mortality 30 Days And 3-5 Years After Endo Repair Of Juxtarenal And Complex AAAs In The UK Compass Trial (Real World) Is Double That Of Open Repairs: Why Is This So And Why Is This Different Than Results From US Single Centers And The ARC Registry
  Presenter(s):S. Rao Vallabhaneni, MD, FRCS / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
Location: Grand Ballroom East, 3rd Floor
2:12 PM - 2:17 PM DEBATE: Mortality Early And 3-5 Years After Endo Repair Of Juxtarenal And Complex AAAs In The US Aortic Research Consortium (ARC) Registry Is Less Than That Reported For Comparable Open Repairs
  Presenter(s):Andres Schanzer, MD  
Location: Grand Ballroom East, 3rd Floor
2:18 PM - 2:23 PM Why EVAR Should Be Preferred Over Open Repair In Young Patients With Suitable Anatomy: From A Meta-Analysis Of >50,000 Patients
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
Location: Grand Ballroom East, 3rd Floor
2:24 PM - 2:30 PM Panel Discussion
2:30 PM - 2:40 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 5
previous next